Vimarsana
Biggest News Aggregation in the World

Rob Seitz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rob Seitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rob Seitz Today - Breaking & Trending Today

2022-05-26 | NDAQ:OCX | Press Release | ONCOCYTE CORPORATION - Vimarsana News

2022-05-26 | NDAQ:OCX | Press Release | ONCOCYTE CORPORATION

Published: May 26, 2022

(2022-05-26 | NDAQ:OCX) Oncocyte Presents DetermaIO(TM) Data at ASCO 2022 Supporting the Test's Potential to Expand the Clinical Use of Immunotherapy

Source: stockhouse.com
Related Topics:
United StatesHeinz Josef LenzRob SeitzOncocyte ClosecurlyquoteCharu AggarwalDavid GandaraPriyanka SharmaMegan KernanChiara CremoliniMd Uc Davis Comprehensive Cancer CenterEarly Access ProgramCancer FoundationAbramson Cancer CenterExchange CommissionAmerican Society Of Clinical Oncology Annual MeetingAsian Cancer Research GroupCompany ClosecurlyquoteOncocyte CorporationNorris Comprehensive Cancer CenterUniversity Of PennsylvaniaOncocyte Corporation NasdaqMd University Of Kansas Medical CenterCancer Genome Atlas ProgramAmerican SocietyClinical Oncology Annual Meeting
Oncocyte Publishes Study Demonstrating Predictive Potential - Vimarsana News

Oncocyte Publishes Study Demonstrating Predictive Potential

Published: October 2, 2021

Data show that DetermaIO demonstrates superior accuracy compared to standard of care PD-L1 IHC for predicting a patient’s response to immunotherapy...

Source: globenewswire.com
Related Topics:
Oncocyte DetermaNeoadjuvant ImmunochemotherapyRob SeitzBob YedidMegan KernanExchange CommissionYale UniversityOncocyte CorporationLifesci AdvisorsOncocyte Corporation NasdaqBaylor UniversityNovel ImmunomodulatoryGene SignaturePredict ResponsePrimary Triple Negative BreastTriple Negative Breast CancerImmune OncologyForward LookingSci AdvisorsNasdaq OcxOncocyte Corporation